-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Eterna Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2010 to Q3 2024.
- Eterna Therapeutics Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 5.41M shares, unchanged year-over-year.
- Eterna Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 5.31M shares, a 74.2% increase from 2022.
- Eterna Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 3.05M shares, a 40.9% increase from 2021.
- Eterna Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 2.17M shares, a 87.7% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)